Amy Hsu
Principal Research Associate, Analytical Development Astellas Gene Therapies
Seminars
Thursday 3rd December 2026
Characterization of Host Cell DNA Impurities in AAV Products: A Product Specific Qualification Method & DNA Fragment Size Assessment
2:15 pm
- rAAV as a Gene Therapy Product
- Gene Therapy Critical Quality Attributes (CQA)
- Overview Methods for Residual Host Cell DNA Quantification
- Method Development for Residual Host Cell DNA Quantification
- Residual Host Cell DNA Sizing in rAAV Gene Therapy Product
